Christopher C. Woller
Lawyers
Filters
Charles River Laboratories acquisition of Vigene Biosciences
We are advising Charles River on the acquisition
Hydrofarm Holdings Group $310.6 million follow-on offering
We advised the underwriters in connection with the equity offering
Ultra Clean $175 million follow-on offering
We advised Ultra Clean on its SEC-registered equity offering
Tempur Sealy $800 million senior notes offering
We advised the initial purchasers on the high-yield debt offering
PLAYSTUDIOS business combination with Acies Acquisition
We are advising PLAYSTUDIOS on its combination with Acies, a SPAC
Cryoport $287.5 million follow-on offering
We advised the underwriters on the SEC-registered offering
CytomX Therapeutics $100 million follow-on offering
We advised the joint book-running managers in connection with the equity offering
Editas Medicine $231 million stock offering
We advised the joint book-running managers in connection with the equity offering
Affirm Holdings $1.39 billion IPO
The shares are listed on the Nasdaq Global Select Market
NeoGenomics $230 million stock and $345 million convertible notes offerings
We advised the joint book-running managers on the public offerings of stock and convertible notes